The IRCI (International Rare Cancers Initiative) trials are each presented to exemplify possible approaches to designing credible trials in rare cancers. Researchers may consider these for use in future trials and understand the choices made for each design.
View this resource Bookmark this resource
Clinical trial designs for rare diseases: Studies developed and discussed by the International Rare Cancers Initiative (Bogaerts et al., 2015)
Published by ECRINArticle authors
Clinical Trials Toolkit